ClinicalTrials.govpublic full text
Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study
advanced hodgkin lymphoma, brentuximab vedotin, phase 2, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 907300
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.